Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

NCT07067463

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Pheonix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
  • Regina Berkovich MD, PhD Inc. West Hollywood, California, United States
  • Nova Clinical Research, LLC Bradenton, Florida, United States
View all 41 locations
View Trial Details
Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Perseverance Research Center, LLC (PRC) Scottsdale, Arizona, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Regina Berkovich MD, PhD Inc West Hollywood, California, United States
View all 23 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 103 locations
View Trial Details
Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NCT06796504

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Shepherd Center Atlanta, Georgia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Minnesota Center for Multiple Sclerosis Plymouth, Minnesota, United States
  • The University of Texas Health Science Center at Houston Houston, Texas, United States
View Trial Details
Recruiting

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

NCT06733922

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Charcot-Marie-Tooth disease, Type 1F, +7 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Burnaby, British Columbia, Canada
View all 14 locations
View Trial Details

Related conditions